Loss of INI 1 Protein Expression
1 clinical trials · Condition
◉ Watch Loss of INI 1 Protein Expression
| Record | Firm | Date |
|---|---|---|
| Phase II Trial of Nivolumab Plus Ipilimumab in Patients With Renal Medullary Carcinoma (NCT03274258) | M.D. Anderson Cancer Center | 2018-05-29 |
Track Loss of INI 1 Protein Expression automatically
Every clearance here is in the API, with alerts when new ones post.